Skip to main content

What are you looking for?

Write the name, title or any keyword related to what you are looking for and select which content category it belongs to.

News

The Ministry of Science and Innovation grants €1.4 million to the DIAGBI project to facilitate the early and non-invasive diagnosis of brain tumours

The Ministry of Science and Innovation granted more than €1.4 million to the project "Early molecular nanoDIAGnostics of Brain tumours using ImmunePET (DIAGBI)" which will be developed between 2021 and 2024 with the participation of the Vall d’Hebron Research Institute through the Molecular Medic

News

Vall d’Hebron identifies a new strategy which will help understand the causes of strokes

An analysis of thrombi would allow the cause of a stroke to be detected and therefore permit the selection of an appropriate treatment to prevent a stroke and to carry out a more thorough follow-up.

News

The first of Vall d’Hebron Innovation and Science Week comes to an end

All the activities associated with virtual and augmented reality, robotics, simulation, 3D, entrepreneurship and research came to an end after five days.

News

A Vall d'Hebron study allows optimizing the treatment of patients with severe damage in their lungs after COVID-19

Biopsies obtained by flexible bronchoscopy have been used to analyze which patients have sequelae in the lung in order to recommend, if necessary, the administration of corticosteroids as a treatment.

News

Vall d’Hebron includes the first patient in a clinical trial for Oryzon to treat schizophrenia

The EVOLUTION trial is currently in phase IIb and it will evaluate the effect of the Vafidemstat drug on cognitive effects and the negative effects deriving from the illness.

News

Two researchers at VHIR among the most cited in the world in 2021

Among the 108 Spanish scientists recognised on the 2021 Web of Science Group list, two from Vall d’Hebron Research Institute stand out: Dr Maria Buti and Dr Xavier Montalban.

News

Vall d'Hebron identifies a therapeutic target for the treatment of chemotherapy-resistant head and neck carcinoma

The team led by Dr. Matilde E. LLeonart has observed the presence of elevated levels of syntenin-1 in chemotherapy-resistant cells and cancer stem cells.

News

Vall d'Hebron organitza la primera Setmana de la Innovació i la Ciència. T'hi vols apuntar?

La Setmana de la Innovació i la Ciència a Vall d’Hebron seran cinc dies plens d’activitats relacionades amb la realitat virtual i augmentada, la robòtica, la simulació, el 3D, l’emprenedoria o la recerca.

News

Vall d’Hebron and Salus.Coop sign a cooperation agreement to carry out research projects into COVID-19 by donating data

Within the framework of the project “Cooperative Cohort COVID-19”, a mobile application will allow citizens to transfer their data under certain conditions and thus actively collaborate in research projects.

News

Dr Magda Campins, ACRA award for the best professional career

The jury unanimously recognised her efforts in the fight against COVID-19 and the cooperation with the care sector for dependent elderly people.

News

Two VHIR projects receive a grant from the AECC for their advances in cancer research

The AECC Research Grants for 2021 will drive the research headed by Dr Fernanda da Silva and Dr Eva Colás.

News

A Vall d'Hebron project receives a grant from the Spanish Society of Nephrology (SEN) and the Senefro Foundation

The grant will allow to carry out a validation study of a digital tool for monitoring patients with advanced diabetic kidney disease.

News

Dr. Ferran Pellisé leads a study that demonstrates the reduction of complications after scoliosis surgery

The analysis aimed to identify trends in indicators of quality of care in the surgical treatment of adult scoliosis, such as complications, reinterventions and impact on the quality of life of patients with spinal deviation.

News

Vall d’Hebron welcomes the assembly of the members of the European University Hospital Alliance

Dr Albert Salazar, director of Vall d’Hebron and Chairman of the EUHA highlighted “the significance of this alliance, which allows us to establish synergies with Europe and thus improve patient care”.

News

Vall d’Hebron joins Movember to raise awareness of male health problems

Prostate cancer, testicle cancer, mental health and preventing suicide among men were the focus of the charity organisation Movember, which since 2003 has funded more than 1,250 projects associated with male health around the world.

News

Vall d’Hebron is looking for volunteers to participate in the Phase IIb study of the HIPRA vaccine against COVID-19

Vall d’Hebron is looking for volunteers over the age of 18 who have received the Pfizer-BioNTech Comirnaty vaccine against COVID-19 at least 6 months ago.

News

Dr. Lucas Moreno receives a grant to advance research in pediatric oncology

The Fight Kids Cancer initiative (a union of three European cancer associations: Imagine for Margo, Kick Cancer and Kriibskrank Kanner Foundation) is the funding institution.

News

Una nova donació de Pulseras Candela per impulsar la recerca de Vall d’Hebron en ependimoma pediàtric

L’Associació Pulseras Candela consolida la seva col·laboració amb una nova aportació de 50.000€ al projecte del Dr. Miquel Segura i la Dra. Roberta Antonelli del VHIR.

News

Vall d'Hebron Research Institute participates in the 19th SENC Convention

As of tomorrow, Lleida will be hosting the 19th Congress of the Spanish Society of Neuroscience (SENC). This is a biennial event, which this year will be held from 3 to 5 November in la Llotja, the Lleida Exhibition Centre, with the presence of the Vall d'Hebron Research Institute.

News

Tret de sortida a un estudi per analitzar els mecanismes immunopatogènics i l’efecte de la vacunació en persones amb COVID-19 persistent

Hi participaran 300 persones en set centres repartits per tota Catalunya, entre els quals es troba Vall d'Hebron.